Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial

Hypertension

Volumn 31, Issue 3, 1998, Pages 823-829

  Plouin, Pierre François ^a,b   Chatellier, Gilles ^a   Darné, Bernadette ^a   Raynaud, Alain ^a  

^a HÔPITAL BROUSSAIS   (France)

^b INSERM   (France)

Author keywords

Angioplasty, balloon; Atherosclerosis; Randomized controlled trials; Renal artery obstruction

Indexed keywords

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY DISSECTION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY INFARCTION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; RESTENOSIS; REVASCULARIZATION; SCORING SYSTEM; TREATMENT OUTCOME; VASCULAR SURGERY;

EID: 0031886316     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.3.823     Document Type: Article

References (25)

1. Derkx FHM, Schalekamp MADH. Renal artery stenosis and hypertension. Lancet. 1994;344:237-239.
2. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712-719.
3. Semple PF, Dominiczak AF. Detection and treatment of renovascular disease: 40 years on. J Hypertens. 1994;12:729-734.
4. Anderson GH Jr, Blakeman N, Streeten DHP. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609-615.
5. Berglund G, Andersson O, Wilhelmsen L. Prevalence of primary and secondary hypertension: studies in a random population sample. BMJ. 1976;2:554-556.
6. Lewin A, Blaufox MD, Castle H, Entwisle G, Langford H. Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med. 1985;145:424-427.
7. Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med. 1994;96:10-14.
8. Davidson RA, Wilcox CS. Newer tests for the diagnosis of renovascular disease. JAMA. 1992;268:3353-3358.
9. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthén UL, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg. 1993;18:841-852.
10. Blum U, Krumme B, Flügel P, Gabelmann A, Lehnert T, Buitrago-Tellez C, Schollmeyer P, Langer M. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459-465.
11. Harden PN, MacLeod MJ, Rodger RSC, Baxter GM, Connell JMC, Dominiczak AF, Junor BJR, Briggs JD, Moss JG. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349: 1133-1136.
12. Brawn LA, Ramsay LE. Is improvement real with percutaneous transluminal angioplasty in the management of renovascular hypertension? Lancet. 1987;2:1313-1316.
13. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. J Hypertens. 1994;12:1312. Abstract.
14. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ. 1990;300:569-572.
15. Bottini PB, Carr AA, Rhoades RB, Prisant LM. Variability of indirect methods used to determine blood pressure: office vs mean 24-hour automated blood pressures. Arch Intern Med. 1992;152:139-144.
16. Merlo J, Wessling A, Melander A. Comparison of dose standard units for drug utilisation studies. Eur J Clin Pharmacol. 1996;50:27-30.
17. Cockcroft DW, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
18. Plouin PF, Darné B, Chatellier G, Pannier I, Battaglia C, Raynaud A, Azizi M. Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension. 1993;21:89-96.
19. Jamieson MJ, Webster J, Witte K, Huggins MM, MacDonald TM, De Beaux A, Petrie JC. An evaluation of the A&D UA-751 semi-automated cuff-oscillometric sphygmomanometer. J Hypertens. 1990;8:377-381.
20. Malher F, Triller J, Weidmann P, Nachbur B. Complications in percutaneous transluminal dilatation of renal arteries. Nephron. 1986;44(suppl 1):60-63.
21. Canzanello VJ, Millan VG, Spiegel JE, Ponce SP, Kopelman RI, Madias NE. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension. 1989;13:163-172.
22. Miyamori I, Yasuhara S, Matsubara T, Takasaki H, Takeda R. Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension. Am J Hypertens. 1988;1:359-363.
23. Streeten DHP, Anderson GH, Wagner S. Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens. 1990;3:360-365.
24. Abuelo JG. Diagnosing vascular causes of renal failure. Ann Intern Med. 1995;123:601-614.
25. Pickering TG, Devereux RB, James GD, Silane MF, Herman L, Sotelo JE, Sos TA, Laragh JH. Recurrent pulmonary edema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularization. Lancet. 1988;2:551-552.